Last Monday, Wemos spoke to the Development Committee of the European Parliament. In addition to Members of the European Parliament (MEPs), representatives of the European Medicines Agency (EMA) and the European Commission (EC) attended the meeting.

Wemos gave a presentation on clinical drug trials on people in developing countries, mostly for drugs intended for the Western market. The exploitation of vulnerable trial subjects and failing supervision in developing countries leads to unacceptable situations. Therefore Wemos called on the European Medicines Agency and the European Commission to take steps to ensure that unethically tested drugs do not get access to the European market. Several MEPs supported Wemos‘ call by asking the EMA and EC representatives about their willingness to take such steps.

The coming period, Wemos will be lobbying actively at the European level. Please visit our website for updates or follow us on Twitter.

Related article: ‘Lobby pays off’